Clinical trial / 2017
Disrupting slow wave sleep acutely increased cerebrospinal fluid amyloid-β40 levels in healthy adults.
Seventeen healthy adults underwent 5-14 days of actigraphy followed by slow wave activity disruption during polysomnogram, compared to an identical sham protocol, with cerebrospinal fluid collected the following morning. Specific disruption of slow wave activity correlated with an increase in amyloid-β40 (r = 0.610, P = 0.009), an effect not observed for sleep duration, sleep efficiency, total protein, tau, YKL-40, or hypocretin. In addition, worse home sleep quality measured by actigraphy over the preceding six nights was associated with higher tau levels (r = 0.543, P = 0.045).
- Study type
- Experimental intervention study with sham control
- Who was studied
- 17 healthy adults (aged 35-65 years) without sleep disorders
- What was measured
- Cerebrospinal fluid levels of amyloid-β, tau, total protein, YKL-40, and hypocretin
THE PAPER
Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levels.
Ju YS, Ooms SJ, Sutphen C, Macauley SL, Zangrilli MA, Jerome G, Fagan AM, Mignot E, Zempel JM, Claassen JAHR, Holtzman DM. Brain, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.